COFIDES is investing €1.05 million in Procare Health to support its expansion into Italy through the establishment of a subsidiary and enhanced clinical research capabilities.
Target Information
Procare Health, a Catalonian pharmaceutical laboratory, specializes in the development and commercialization of natural ingredient-based products aimed at women's health and wellness. The company has strategically advanced its international expansion following successful operations in Italy through a distributor over recent years. With a diverse portfolio of products addressing common issues such as infertility, vaginal infections, HPV-related cervical injuries, and osteoarthritis, Procare Health has reached over 75 countries worldwide.
Procare Health dedicates up to 25% of its budget to research and development, collaborating with various international medical and pharmaceutical institutions. This commitment to innovation positions the company favorably in an increasingly competitive market.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Italy
The Italian pharmaceutical industry is a dynamic sector characterized by a strong commitment to research and innovation. With a robust public healthcare system and a growing demand for healthcare products, Ita
Similar Deals
Carlyle and Arcmont Asset Management → Bianalisi
2025
Hark Capital → Pharos IV-A, L.P.
2025
COFIDES → WIVI Vision
2025
CareHub → Centro Diagnostico Moscardi S.r.l., Diagnostica Moderna S.r.l., Fisiomedical S.r.l.
2025
COFIDES
invested in
Procare Health
in 2025
in a Venture Debt deal
Disclosed details
Transaction Size: $1,035M